Updated Jan 16, 2018

Nanobiosym pilot project for optimization and evaluation of the Gene-RADAR® point-of-care diagnostic device for identification of HIV treatment failure and prevention of drug-resistant HIV in Rwanda

http://www.biggerfuture.com/

The innovation has no owner

CLAIM IT

Snapshot

Stage 3: Proof of Concept

Focus Areas:

Health, Non-communicable Diseases, Youth and 2 MoreSEE MORE

Health, Non-communicable Diseases, Youth, Monitoring & Evaluation and Social and Behavior ChangeSEE LESS

Implemented In:

Rwanda

RwandaSEE LESS

1
Country Implemented In
Verified Funding

Innovation Description

Developing the pilot trial for Gene-RADAR®, a platform that is a portable, low cost, point-of-care diagnostic that quantifies viral load of HIV strains in under an hour.
How does your innovation work?
We are designing a pilot trial in Rwanda for its Gene-RADAR® platform, a platform capablue of quantifying a viral load of HIV strains in under an hour, without the need for conventional lab infrastructure. This will provide life-saving treatment for people living with HIV and prevent the spread of drug-resistant strains in Africa and beyond.

Milestones

Oct 2015
Aug 2013
May 2013
Funds RaisedVERIFIED
$84,750
Date Unknown
Launched
Date Unknown
New Country
Rwanda